Wayne suggested in his last video interview that there is a complex balance to be struck between what can be obtained from an early partnership and holding out until after further results to obtain better value. Personally, I would be happy with delaying a deal until the results prompt serious buying competition between the big players.
Ann: DurAVR valve patient outcomes exceed expectations, page-8
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.15 |
Change
-0.050(0.38%) |
Mkt cap ! $278.8M | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.23 | $13.01 | $68.23K | 5.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 428 | $13.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.15 | 141 | 1 |
View Market Depth
| Last trade - 12.10pm 02/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |